Dr Reddy's Laboratories Ltd. (RDY)

Trade RDY now with
9/16/2019 3:37:58 AM Dr. Reddy's Launches Lansoprazole Delayed-Release Capsules USP, 15 Mg In US
9/11/2019 7:27:57 AM Dr. Reddy's Laboratories Unveils Fosaprepitant For Injection In The U.S. Market
7/23/2019 6:29:38 AM Dr. Reddy's Laboratories Announces Launch Of Ramelteon Tablets, In U.S. Market
6/25/2019 6:27:36 AM Dr. Reddy's Unveils Tobramycin Inhalation Solution, USP In U.S. Market
6/14/2019 1:43:15 AM Dr. Reddy's To Sell Neurology Branded Products To Upsher-Smith Laboratories
6/14/2019 12:13:02 AM Upsher-Smith Laboratories Agrees To Acquire Tosymra And Zembrace SymTouch
5/17/2019 11:04:32 AM Dr. Reddy's Laboratories Q4 EPS $0.38 Vs $0.26 Last Year
3/27/2019 4:29:21 AM Dr. Reddy's Laboratories Launches Tadalafil Tablets USP In The U.S. Market
2/19/2019 2:33:42 AM New Drugs Approved In January
2/4/2019 12:55:16 AM Dr. Reddy’s Continues Recall Of Lot ABD807 Of Levetiracetam In 0.54% Sodium Chloride Injection, 1,500 Mg/100 ML
2/1/2019 10:29:11 AM Dr. Reddy’s Appoints Marc Kikuchi As CEO, North America Generics
2/1/2019 7:47:16 AM Dr. Reddy’s Q3 EPS $0.42 Vs $0.29 Last Year